跳至主要内容
临床试验/IRCT20240410061463N1
IRCT20240410061463N1尚未招募2 期

The Efficacy of Risperidone in treatment of Developmental stuttering in Persian adolescents aged 12-18 years old

Babol University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 18 years(—)
性别
All

入选标准

  • Age range from 12 to 18 years
  • Persian language
  • Be literate in reading and writing
  • Having a diagnosis of permanent developmental stuttering disorder based on the following criteria, the presence of both criteria is necessary: ??• Diagnosis of developmental stuttering by an experienced speech and language pathologist at the time of study • Obtaining a total score of 12 or higher in Riley's Stuttering Severity Test (SSI- 3)
  • Absence of any language or speech disorder other than stuttering in the past or present (will be checked by self-reporting by each participant)
  • Absence of any type of neurological, movement, vision, hearing, mental retardation, and autism spectrum disorders in the past or present, except for attention deficit hyperactivity disorder (ADHD) (with a clinical diagnosis by a psychiatrist)
  • Not taking drugs affecting cognitive function before or during the research (self-reporting will be checked by each participant)

排除标准

  • The person's unwillingness to cooperate in every stage of the research

研究者

相似试验